FI952859A0 - Antacidkomposition och dess framställningsförfarande - Google Patents

Antacidkomposition och dess framställningsförfarande

Info

Publication number
FI952859A0
FI952859A0 FI952859A FI952859A FI952859A0 FI 952859 A0 FI952859 A0 FI 952859A0 FI 952859 A FI952859 A FI 952859A FI 952859 A FI952859 A FI 952859A FI 952859 A0 FI952859 A0 FI 952859A0
Authority
FI
Finland
Prior art keywords
preparation
antacid composition
antacid
composition
Prior art date
Application number
FI952859A
Other languages
English (en)
Finnish (fi)
Other versions
FI952859A (sv
Inventor
Gary G Liversidge
Gregory L Mcintire
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Publication of FI952859A publication Critical patent/FI952859A/sv
Publication of FI952859A0 publication Critical patent/FI952859A0/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI952859A 1992-12-11 1995-06-09 Antacidkomposition och dess framställningsförfarande FI952859A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98929692A 1992-12-11 1992-12-11
PCT/US1993/011720 WO1994013304A2 (en) 1992-12-11 1993-12-03 Antacid composition and method of production

Publications (2)

Publication Number Publication Date
FI952859A FI952859A (sv) 1995-06-09
FI952859A0 true FI952859A0 (sv) 1995-06-09

Family

ID=25534976

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952859A FI952859A0 (sv) 1992-12-11 1995-06-09 Antacidkomposition och dess framställningsförfarande

Country Status (10)

Country Link
EP (1) EP0673253A1 (sv)
JP (1) JPH08504442A (sv)
KR (1) KR950703982A (sv)
AU (1) AU6390894A (sv)
CA (1) CA2150383A1 (sv)
CZ (1) CZ148695A3 (sv)
FI (1) FI952859A0 (sv)
NO (1) NO952261L (sv)
SK (1) SK76595A3 (sv)
WO (1) WO1994013304A2 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2123152T3 (es) * 1993-08-24 1999-01-01 Kappa Pharmaceuticals Ltd Absorcion reducida de acidos grasos.
AU2585395A (en) 1994-05-09 1995-11-29 Chiron Corporation Retroviral vectors having a reduced recombination rate
US5874112A (en) * 1997-03-31 1999-02-23 Mcneil Ppc-Inc. Translucent antacid suspension
AU2002951438A0 (en) * 2002-09-17 2002-10-03 Nauveau Technology Investments Ltd Methods and compositions for treatment of excess stomach acid in mammals
RU2013148719A (ru) * 2013-10-31 2015-05-10 Геннадий Гильфанович Галимов Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата
WO2016104367A1 (ja) * 2014-12-22 2016-06-30 株式会社Ｌｔｔバイオファーマ 機能性ディスペプシア治療薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843778A (en) * 1970-04-28 1974-10-22 Rorer Inc William H Antacids
US4271142A (en) * 1979-06-18 1981-06-02 Life Savers, Inc. Portable liquid antacids
FR2512344A1 (fr) * 1981-09-08 1983-03-11 Af Aplicaciones Far Lab Procede de fabrication d'une suspension stable d'hydroxyde d'alumine et/ou d'hydroxyde de magnesie comme agent actif des antacida

Also Published As

Publication number Publication date
JPH08504442A (ja) 1996-05-14
WO1994013304A3 (en) 1994-09-01
EP0673253A1 (en) 1995-09-27
NO952261D0 (no) 1995-06-08
KR950703982A (ko) 1995-11-17
FI952859A (sv) 1995-06-09
CZ148695A3 (en) 1995-12-13
NO952261L (no) 1995-06-08
SK76595A3 (en) 1997-01-08
WO1994013304A2 (en) 1994-06-23
CA2150383A1 (en) 1994-06-23
AU6390894A (en) 1994-07-04

Similar Documents

Publication Publication Date Title
FI945362A (sv) Förfarande för framställning av monocyklopentadienylmetallkomplexföreningar och förfarande användning av dem
FI101310B1 (sv) Polymerkomposition och förfarande för dess framställning
FI971495A0 (sv) Skumdämpningskomposition och förfarande för dess användning
BR8803728A (pt) Composicao e metodo de revestimento
BR8901250A (pt) Composicao oral e processo de inibir calculo dental
FI891243A (sv) Finformat kiselsyrasol och förfarande för framställning av detta
FR2577139B1 (fr) Composition de vaccin et mode de sa preparation
MX9205721A (es) Metodo de uso y composiciones de win 49596-finasteride
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
KR880701694A (ko) 내화성 조성물 및 내화 피복 공법
FI942932A0 (sv) Farmaceutisk komposition och förfarande för dess framställning
AU1114388A (en) Anesthetic composition and method of using the same
FI896073A0 (sv) Fast detergentblock och förfarande för dess framställning
PT87347A (pt) Method of purifying polydextrose and composition containing same
FI945427A0 (sv) Enantiomerer av dynemicinanaloger, framställning och användning därav
FI952859A0 (sv) Antacidkomposition och dess framställningsförfarande
FI955123A (sv) Komposition innehållande kolestyramin och förfarande för framställning av densamma
AU623165B2 (en) Method of inhibiting the spread of disease and infection in structures
ZA897446B (en) Antimicrobial composition and method of use
FI955399A0 (sv) Polyolsammansättning, förfarande för framställning av denna och användning av denna
EP0445239A4 (en) Anti-malarial composition and method of use
FI940153A0 (sv) Obrännbar kompositstruktur och förfarande för framställning av denna
EE9400182A (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu
FI945493A0 (sv) Framställning av en Ti(III)haltig lösning och användning därav
EE03101B1 (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline kompositsioon

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NANOSYSTEMS L.L.C.

FD Application lapsed